CT-based Postimplant Dosimetry of Prostate Brachytherapy: Comparison of 1-mm and 5-mm Section CT

Overview

Journal Radiat Med

Specialties Nuclear Medicine
Oncology
Radiology

Date 2007 Jan 17

PMID 17225049

Citations 1

Authors

Osamu Tanaka

Shinya Hayashi

Masayuki Kanematsu

Masayuki Matsuo

Masahiro Nakano

Sunaho Maeda

Takashi Deguchi

Hiroaki Hoshi

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to compare the outcomes between 1-mm and 5-mm section computed tomography (CT)-based postimplant dosimetry.

Materials And Methods: A series of 21 consecutive patients underwent permanent prostate brachytherapy. The postimplant prostate volume was calculated using 1-mm and 5-mm section CT. One radiation oncologist contoured the prostate on CT images to obtain the reconstructed prostate volume (pVol), prostate V(100) (percent of the prostate volume receiving at least the full prescribed dose), and prostate D(90) (mean dose delivered to 90% of the prostate gland). The same radiation oncologist performed the contouring three times to evaluate intraobserver variation and subjectively scored the quality of the CT images.

Results: The mean +/-1 SD postimplant pVol was 20.17 +/- 6.66 cc by 1-mm section CT and 22.24 +/- 8.48 cc by 5-mm section CT; the difference in the mean values was 2.06 cc (P < 0.01). The mean postimplant prostate V(100) was 80.44% +/- 7.06% by 1-mm section CT and 77.33% +/- 10.22% by 5-mm section CT. The mean postimplant prostate D(90) was 83.28% +/- 10.81% by 1-mm section CT and 78.60% +/- 15.75% by 5-mm section CT. In the evaluation of image quality, 5-mm section CT was assigned significantly higher scores than 1-mm section CT. In regard to intraobserver variation, 5-mm section CT revealed less intraobserver variation than 1-mm section CT.

Conclusion: Our current results suggested that the outcomes of postimplant dosimetry using 1-mm section CT did not improved the results over those obtained using 5-mm section CT in terms of the quality of the CT image or reproducibility.

Citing Articles

A magnetic resonance-based seed localization method for I-125 prostate implants.

Lee R, Suh H, Lee K, Lim S, Kim Y, Kim S J Korean Med Sci. 2007; 22 Suppl:S129-33.

PMID: 17923739 PMC: 2694378. DOI: 10.3346/jkms.2007.22.S.S129.

References

Polo A, Cattani F, Vavassori A, Origgi D, Villa G, Marsiglia H . MR and CT image fusion for postimplant analysis in permanent prostate seed implants. Int J Radiat Oncol Biol Phys. 2004; 60(5):1572-9. DOI: 10.1016/j.ijrobp.2004.08.033. View

Merrick G, Butler W, Dorsey A, Lief J . The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys. 1999; 44(5):1111-7. DOI: 10.1016/s0360-3016(99)00137-6. View

DuBois D, Prestidge B, Hotchkiss L, Prete J, Bice Jr W . Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 1998; 207(3):785-9. DOI: 10.1148/radiology.207.3.9609905. View

Nag S, Beyer D, Friedland J, Grimm P, Nath R . American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999; 44(4):789-99. DOI: 10.1016/s0360-3016(99)00069-3. View

Hoffelt S, Marshall L, Garzotto M, Hung A, Holland J, Beer T . A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer. Int J Radiat Oncol Biol Phys. 2003; 57(1):29-32. DOI: 10.1016/s0360-3016(03)00509-1. View

Potters L, Cao Y, Calugaru E, Torre T, Fearn P, Wang X . A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2001; 50(3):605-14. DOI: 10.1016/s0360-3016(01)01473-0. View

Takahashi Y, Mori S, Kozuka T, Gomi K, Nose T, Tahara T . Preliminary study of correction of original metal artifacts due to 1-125 seeds in postimplant dosimetry for prostate permanent implant brachytherapy. Radiat Med. 2006; 24(2):133-8. DOI: 10.1007/BF02493280. View

Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y . The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000; 46(1):221-30. DOI: 10.1016/s0360-3016(99)00351-x. View

Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque J . Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 1999; 43(1):57-66. DOI: 10.1016/s0360-3016(98)00351-4. View

10.

Al-Qaisieh B, Ash D, Bottomley D, Carey B . Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. Radiother Oncol. 2002; 62(3):267-73. DOI: 10.1016/s0167-8140(01)00475-3. View

11.

Kim Y, Hsu I, Lessard E, Pouliot J, Vujic J . Dose uncertainty due to computed tomography (CT) slice thickness in CT-based high dose rate brachytherapy of the prostate cancer. Med Phys. 2004; 31(9):2543-8. DOI: 10.1118/1.1785454. View

12.

Lee W, Roach 3rd M, Michalski J, Moran B, Beyer D . Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys. 2002; 54(2):457-61. DOI: 10.1016/s0360-3016(02)02950-4. View

13.

Crook J, Milosevic M, Catton P, Yeung I, Haycocks T, Tran T . Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy. 2004; 1(2):66-73. DOI: 10.1016/s1538-4721(02)00014-4. View

14.

Tanaka O, Hayashi S, Matsuo M, Sakurai K, Nakano M, Maeda S . Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006; 66(2):597-602. DOI: 10.1016/j.ijrobp.2006.06.023. View

15.

Fiorino C, Reni M, Bolognesi A, Cattaneo G, Calandrino R . Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol. 1998; 47(3):285-92. DOI: 10.1016/s0167-8140(98)00021-8. View